Introduction
Pompe disease primarily affects skeletal and cardiac muscles. It is difficult to assess therapeutic efficacy of enzyme replacement therapy (ERT) using primary end points based on changes in weakness of large limb-girdle muscles, gait-endurance, and respiratory function, which all depend on variable day-to-day patient performance. In contrast, muscle improvement might be shown by assessing function of very small muscles, such as the stapedius and tensor tympani muscles. We therefore tested whether ERT benefits in Pompe patients can be shown by stapedius reflex testing before and after ERT.
Results
In four Pompe patients, we assessed ipsilateral stapedius reflex thresholds in the right and left ear one and two years after patients received first dosage of biweekly ERT with alglucosidase alfa (Myozyme™, 20 mg/kg KG i.v.). In two patients, stapedius reflex thresholds were also assessed before ERT-onset. Muscle tension of the stapedius and tensor tympani muscles were determined by measuring acoustic impedance at the tympanic membrane in response to single bursts of 0.5, 1, 2 and 4 kHz tones. Reflex thresholds between 70 and 90dB HL are within the normal range; higher responses indicate impaired thresholds. Patient 1 (female, 46 years) had no stapedius reflex responses before ERT-onset, reflex thresholds of 98. 
Conclusion
In untreated Pompe patients, stapedius reflex testing demonstrates impaired small muscle function. After one and two years of ERT, stapedius reflex thresholds improved. Consequently, stapedius reflex testing can objectively demonstrate significant improvement of muscle function with ERT.
